Sympera AI | $10,000,000 | (Apr 2, 2025)
BetterFleet | $15,000,000 | (Apr 1, 2025)
Certified by Founder
Lodge
NETRIS Pharma
start up
France
- Lyon, Rhône-Alpes
- 20/12/2023
- Series A
- $8,223,000
Our collaborators and partners are driven by a desire to contribute to the development of new ways of fighting cancer. The therapies developed by NETRIS Pharma are based on cellular mechanisms identified by a world-renowned research group.
Located in Léon Bérard Cancer Center (Lyon, France), NETRIS Pharma is a unique model of a biotechnology company integrated within a comprehensive cancer center.
- Industry Pharmaceutical Manufacturing
- Website https://www.netrispharma.com/
- LinkedIn https://www.linkedin.com/company/netris-pharma/about/
Isomorphic Labs | $600,000,000 | (Apr 1, 2025)
Sohar Health (YC S23) | $3,800,000 | (Apr 1, 2025)
Marit Health | $3,200,000 | (Apr 1, 2025)
Retym, Inc | $75,000,000 | (Apr 1, 2025)
Ribbon | $8,000,000 | (Apr 1, 2025)
DeepIP | $15,000,000 | (Apr 1, 2025)
Kay.ai | $3,000,000 | (Apr 1, 2025)
GridPoint | $45,000,000 | (Apr 1, 2025)
POCKLA | $1,728,856 | (Apr 1, 2025)